Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma

Carmeliet, 2000, Angiogenesis in cancer and other diseases, Nature, 407, 249, 10.1038/35025220 Kerbel, 2000, Tumor angiogenesis: past, present and the near future, Carcinogenesis, 21, 505, 10.1093/carcin/21.3.505 Folkman, 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med, 1, 27, 10.1038/nm0195-27 Fox, 1996, Tumour angiogenesis, J Pathol, 179, 232, 10.1002/(SICI)1096-9896(199607)179:3<232::AID-PATH505>3.0.CO;2-A Fidler, 1994, The implications of angiogenesis for the biology and therapy of cancer metastasis, Cell, 79, 185, 10.1016/0092-8674(94)90187-2 Shibuya, 1995, Role of VEGF-flt receptor system in normal and tumor angiogenesis, Adv Cancer Res, 67, 281, 10.1016/S0065-230X(08)60716-2 Dvorak, 1995, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis, Am J Pathol, 146, 1029 Karkkainen, 2000, Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis, Oncogene, 19, 5598, 10.1038/sj.onc.1203855 Nugent, 2000, Fibroblast growth factor-2, Int J Biochem Cell Biol, 32, 115, 10.1016/S1357-2725(99)00123-5 Gospodarowicz D Fibroblast growth factor. Chemical structure and biologic function 1990 231 248 Gospodarowicz D Neufeld G Schweigerer L Fibroblast growth factor: structural and biological properties 1987 15 26 Kandel, 1991, Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma, Cell, 66, 1095, 10.1016/0092-8674(91)90033-U Mise, 1996, Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor, Hepatology, 23, 455, 10.1002/hep.510230309 Samoto, 1995, Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors, Cancer Res, 55, 1189 Suzuki, 1996, Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma, Cancer Res, 56, 3004 Yoshiji, 1996, Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer, Cancer Res, 56, 2013 Yamaguchi, 1998, Expression of vascular endothelial growth factor in human hepatocellular carcinoma, Hepatology, 28, 68, 10.1002/hep.510280111 Waltenberger, 1994, Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor, J Biol Chem, 269, 26988, 10.1016/S0021-9258(18)47116-5 Kroll, 1997, The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells, J Biol Chem, 272, 32521, 10.1074/jbc.272.51.32521 Millauer, 1996, Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo, Cancer Res, 56, 1615 Goto, 1993, Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels, Lab Invest, 69, 508 Seghezzi, 1998, Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis, J Cell Biol, 141, 1659, 10.1083/jcb.141.7.1659 Mandriota, 1997, Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor, J Cell Sci, 110, 2293, 10.1242/jcs.110.18.2293 Hata, 1999, Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway, Diabetes, 48, 1145, 10.2337/diabetes.48.5.1145 Tokuda, 2000, Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase, J Bone Miner Res, 15, 2371, 10.1359/jbmr.2000.15.12.2371 Saadeh, 2000, Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells, Endocrinology, 141, 2075, 10.1210/endo.141.6.7502 Majima, 2000, Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants, Br J Pharmacol, 130, 641, 10.1038/sj.bjp.0703327 Asahara, 1995, Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo, Circulation, 92, II365, 10.1161/01.CIR.92.9.365 Cheng, 1996, Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor, Proc Natl Acad Sci U S A, 93, 8502, 10.1073/pnas.93.16.8502 Yoshiji, 1997, Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells, Cancer Res, 57, 3924 Giavazzi, 2001, Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors, Cancer Res, 61, 309 Coltrini, 1995, Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action, Cancer Res, 55, 4729 Wang, 1997, Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth, Nat Med, 3, 887, 10.1038/nm0897-887 Simonetti, 1991, Hepatocellular carcinoma. A worldwide problem and the major risk factors, Dig Dis Sci, 36, 962, 10.1007/BF01297149 Hatori, 1994, Epidemiology of liver cancer in Japan, J Clin Exp Med, 171, 1097 Ogasawara, 1996, Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines, Hepatology, 24, 198, 10.1002/hep.510240132 Kin, 1997, Basic fibroblast growth factor regulates proliferation and motility of human hepatoma cells by an autocrine mechanism, J Hepatol, 27, 677, 10.1016/S0168-8278(97)80085-2 Chow, 1998, Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma, Dig Dis Sci, 43, 2261, 10.1023/A:1026670723302 Yoshiji, 1998, Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells, Hepatology, 28, 1489, 10.1002/hep.510280607 Yoshiji, 1999, KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells, Hepatology, 30, 1179, 10.1002/hep.510300509 Gossen, 1992, Tight control of gene expression in mammalian cells by tetracycline-responsive promoters, Proc Natl Acad Sci U S A, 89, 5547, 10.1073/pnas.89.12.5547 Gately, 1995, Cells transfected with the basic fibroblast growth factor gene fused to a signal sequence are invasive in vitro and in situ in the brain, Neurosurgery, 36, 780, 10.1227/00006123-199504000-00020 Einar, 2000, Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts, Cancer Res, 60, 4932 Yoshiji, 1999, Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis, Cancer Res, 59, 4413 Yoshiji, 2001, The angiotensin-I converting enzyme inhibitor, perindopril, suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor, Clin Cancer Res, 7, 1073 Tanigawa, 1997, Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance, Hepatology, 26, 1216 Yoshiji, 2001, Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats, Hepatology, 34, 745, 10.1053/jhep.2001.28231 Gautschi, 2001, Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins, J Natl Cancer Inst, 93, 463, 10.1093/jnci/93.6.463 Bruns, 2000, Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases, Cancer, 89, 488, 10.1002/1097-0142(20000801)89:3<488::AID-CNCR3>3.0.CO;2-X